GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Accounts Payable

XBiotech (STU:4XB) Accounts Payable : €1.58 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Accounts Payable?

XBiotech's Accounts Payable for the quarter that ended in Jun. 2024 was €1.58 Mil.

XBiotech's quarterly Accounts Payable increased from Dec. 2023 (€2.31 Mil) to Mar. 2024 (€2.40 Mil) but then declined from Mar. 2024 (€2.40 Mil) to Jun. 2024 (€1.58 Mil).

XBiotech's annual Accounts Payable increased from Dec. 2021 (€1.83 Mil) to Dec. 2022 (€2.27 Mil) and increased from Dec. 2022 (€2.27 Mil) to Dec. 2023 (€2.31 Mil).


XBiotech Accounts Payable Historical Data

The historical data trend for XBiotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XBiotech Accounts Payable Chart

XBiotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 2.05 1.83 2.27 2.31

XBiotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.38 2.31 2.40 1.58

XBiotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


XBiotech Accounts Payable Related Terms

Thank you for viewing the detailed overview of XBiotech's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


XBiotech Business Description

Traded in Other Exchanges
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech Headlines

No Headlines